Show
Sort by
-
- Journal Article
- A1
- open access
Response to : 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial' by Cai and Peng response
-
Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature
-
- Miscellaneous
- open access
Levelling the playing field of RMD research across Europe to address patients' needs : the emerging EULAR Research Centre
-
Cluster analysis in early axial spondyloarthritis predicts poor outcome in the presence of peripheral articular manifestations
-
- Journal Article
- A1
- open access
Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis : a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR
-
- Journal Article
- A1
- open access
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis : results of the open-label, pragmatic, cluster-randomised TICOSPA trial
-
- Journal Article
- A1
- open access
Validation of the self-administered comorbidity questionnaire adjusted for spondyloarthritis : results from the ASAS-COMOSPA study
-
- Journal Article
- A1
- open access
Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis
-
Prevalence of comorbidities and risk factors for comorbidities in patients with spondyloarthritis in Latin America : a comparative study with the general population and data from the ASAS-COMOSPA study
-
Inequity in biological DMARD prescription for spondyloarthritis across the globe : results from the ASAS-COMOSPA study